Aequus Pharmaceuticals Stock Market Value
| AQSZF Stock | USD 0.01 0.0005 7.04% |
| Symbol | Aequus |
Aequus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aequus Pharmaceuticals' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aequus Pharmaceuticals.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Aequus Pharmaceuticals on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Aequus Pharmaceuticals or generate 0.0% return on investment in Aequus Pharmaceuticals over 720 days. Aequus Pharmaceuticals is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada More
Aequus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aequus Pharmaceuticals' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aequus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 45.35 | |||
| Value At Risk | (10.64) | |||
| Potential Upside | 2.22 |
Aequus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aequus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aequus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Aequus Pharmaceuticals historical prices to predict the future Aequus Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (2.01) | |||
| Treynor Ratio | (0.61) |
Aequus Pharmaceuticals Backtested Returns
Aequus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Aequus Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aequus Pharmaceuticals' Standard Deviation of 6.87, risk adjusted performance of (0.09), and Mean Deviation of 2.82 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.52, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aequus Pharmaceuticals will likely underperform. At this point, Aequus Pharmaceuticals has a negative expected return of -0.94%. Please make sure to confirm Aequus Pharmaceuticals' skewness, as well as the relationship between the day median price and relative strength index , to decide if Aequus Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
Aequus Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Aequus Pharmaceuticals time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aequus Pharmaceuticals price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Aequus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Aequus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Aequus Pharmaceuticals otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aequus Pharmaceuticals' otc stock expected returns. We can calculate the autocorrelation of Aequus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Aequus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aequus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aequus Pharmaceuticals otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aequus Pharmaceuticals otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aequus Pharmaceuticals otc stock over time.
Current vs Lagged Prices |
| Timeline |
Aequus Pharmaceuticals Lagged Returns
When evaluating Aequus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aequus Pharmaceuticals otc stock have on its future price. Aequus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aequus Pharmaceuticals autocorrelation shows the relationship between Aequus Pharmaceuticals otc stock current value and its past values and can show if there is a momentum factor associated with investing in Aequus Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Aequus OTC Stock
Aequus Pharmaceuticals financial ratios help investors to determine whether Aequus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aequus with respect to the benefits of owning Aequus Pharmaceuticals security.